Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRB | P24530 | 16/20 | 0.78 |
| ▸ | EDNRA | P25101 | 16/20 | 0.78 |
| ▸ | FABP7 | O15540 | 2/20 | 0.54 |
| ▸ | FABP3 | P05413 | 2/20 | 0.54 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7943708 | 0.88 | EDNRA (0.79) | EDNRBEDNRA | |
| SCHEMBL7942483 | 0.88 | EDNRA (0.79) | EDNRBEDNRA | |
| SCHEMBL7942478 | 0.88 | EDNRA (0.79) | EDNRBEDNRA | |
| SCHEMBL7538026 | 0.87 | EDNRA (1.00) | EDNRBEDNRA | |
| SCHEMBL6452207 | 0.87 | EDNRA (1.00) | EDNRBEDNRA | |
| SCHEMBL6452202 | 0.87 | EDNRA (1.00) | EDNRBEDNRA | |
| SCHEMBL8626049 | 0.86 | EDNRA (0.59) | EDNRBEDNRAFABP7FABP3FABP5 | |
| SCHEMBL7942494 | 0.85 | EDNRA (0.80) | EDNRBEDNRA | |
| SCHEMBL7533846 | 0.85 | EDNRA (0.83) | EDNRBEDNRA | |
| SCHEMBL7531491 | 0.83 | EDNRA (0.73) | EDNRBEDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6271399-B1 | METHYL 3-(3,4-METHYLENEDIOXYPHENYL)-6-(PROP-1-YLOXY)-INDANE-2-CARBOXYLATE DERIVATIVES | SMITHKLINE BEECHAM CORPORATION | 2001-08-07 | — | — | US | disclosed |
| US-6087389-A | TREATING CARDIOVASCULAR AND RENAL DISEASES INCLUDING HYPERTENSION, ACUTE AND CHRONIC RENAL FAILURE, CYCLOSPORINE INDUCED NEPHROTOXICITY, STROKE, CEREBROVASCULAR VASOSPASM, MYOCARDIAL ISCHEMIA, ANGINA, HEART FAILURE, ATHEROSCLEROSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-07-11 | — | — | US | disclosed |
| US-5817693-A | Endothelin receptor antagonists | SMITHKLINE BEECHAM CORPORATION | 1998-10-06 | — | — | US | disclosed |
| US-5719183-A | HYPOTENSIVE AGENTS; KIDNEY DISEASES; ANTIISCHEMIC AGENTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |
| US-5719182-A | TREATING HYPERTENSION, RENAL FAILURE, CEREBROVASCULAR DISEASE | SMITHKLINE BEECHAM CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |
| US-5716984-A | INDANE AND INDENE DERIVATIVES; TREATMENT OF CARDIOVASCULAR DISORDERS, KIDNEY DISORDERS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-02-10 | — | — | US | disclosed |